NCT02515656View on ClinicalTrials.gov

Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis

PHASE3CompletedINTERVENTIONAL
Enrollment

661

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Vaginitis
Interventions
DRUG

POLYGYNAX®

DRUG

GYNODAKTARIN®

DRUG

Placebo

Trial Locations (4)

69009

PERCEVAL, Lyon

Unknown

TURKOVA, Prague

MARICIC, Belgrade

GATOVA, Martin

Sponsors

Collaborators (1)

Venn Life Sciences
All Listed Sponsors
collaborator

International Clinical Trials Association

OTHER

collaborator

Venn Life Sciences

OTHER

lead

Laboratoire Innotech International

INDUSTRY

NCT02515656 - Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis | Biotech Hunter | Biotech Hunter